- Home
- GEG vs VRCA Comparison
GEG vs VRCA Comparison
Compare GEG & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEG
- VRCA
- Stock Information
- Founded
- GEG 1994
- VRCA 2013
- Country
- GEG United States
- VRCA United States
- Employees
- GEG N/A
- VRCA N/A
- Industry
- GEG Computer Software: Prepackaged Software
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- GEG Technology
- VRCA Health Care
- Exchange
- GEG Nasdaq
- VRCA Nasdaq
- Market Cap
- GEG 72.4M
- VRCA 58.7M
- IPO Year
- GEG N/A
- VRCA 2018
- Fundamental
- Price
- GEG $2.80
- VRCA $4.04
- Analyst Decision
- GEG
- VRCA Hold
- Analyst Count
- GEG 0
- VRCA 5
- Target Price
- GEG N/A
- VRCA $60.00
- AVG Volume (30 Days)
- GEG 902.9K
- VRCA 43.2K
- Earning Date
- GEG 11-10-2025
- VRCA 11-03-2025
- Dividend Yield
- GEG N/A
- VRCA N/A
- EPS Growth
- GEG N/A
- VRCA N/A
- EPS
- GEG 0.38
- VRCA N/A
- Revenue
- GEG $16,315,999.00
- VRCA $14,704,000.00
- Revenue This Year
- GEG N/A
- VRCA $332.45
- Revenue Next Year
- GEG N/A
- VRCA $12.85
- P/E Ratio
- GEG $7.47
- VRCA N/A
- Revenue Growth
- GEG N/A
- VRCA 5.72
- 52 Week Low
- GEG $1.70
- VRCA $3.82
- 52 Week High
- GEG $3.51
- VRCA $20.01
- Technical
- Relative Strength Index (RSI)
- GEG 58.00
- VRCA 25.92
- Support Level
- GEG $2.58
- VRCA $4.35
- Resistance Level
- GEG $2.99
- VRCA $5.23
- Average True Range (ATR)
- GEG 0.25
- VRCA 0.38
- MACD
- GEG -0.01
- VRCA -0.08
- Stochastic Oscillator
- GEG 42.28
- VRCA 4.47
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.